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Abstract
Poor patient compliance to therapy results in a worsening condition that often increases healthcare costs. In the MobiGuide
project, we developed an evidence-based clinical decision-support system that delivered personalized reminders and recommendations to patients, helping to achieve higher therapy compliance. Yet compliance could still be improved and therefore building
on the MobiGuide project experience, we designed a new component called the Motivational Patient Assistant (MPA) that is
integrated within the MobiGuide architecture to further improve compliance. This component draws from psychological theories
to provide behavioral support to improve patient engagement and thereby increasing patients’ compliance. Behavior modification interventions are delivered via mobile technology at patients’ home environments. Our approach was inspired by the IDEAS
(Integrate, Design, Assess, and Share) framework for developing effective digital interventions to change health behavior; it goes
beyond this approach by extending the Ideation phase’ concepts into concrete backend architectural components and graphical
user-interface designs that implement behavioral interventions. We describe in detail our ideation approach and how it was
applied to design the user interface of MPA for anticoagulation therapy for the atrial fibrillation patients. We report results of a
preliminary evaluation involving patients and care providers that shows the potential usefulness of the MPA for improving
compliance to anticoagulation therapy.
Keywords Patient engagement . Atrial fibrillation . Mobile health . Trans-theoretical model

Introduction
Most older adults have at least one chronic disease and chronic diseases account for seven of the ten top causes of death [1].
This article is part of the Topical Collection on Mobile & Wireless Health.
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While evidence-based management of chronic disease can
extend the quality and length of life, almost half of patients
exhibit poor compliance to prescribed therapies [2], especially
for symptomless conditions. Such behavior is linked with a
worsening condition and increased risk of comorbid diseases
resulting in increased healthcare costs [3].
Within the MobiGuide project [4], we developed an
evidence-based clinical decision-support system that monitored patients’ biosignals and delivered personalized reminders and recommendations to care providers and patients,
helping to achieve higher compliance. Indeed, the mean compliance of gestational diabetes patients to the clinical recommendations was about 87%. However, the mean compliance
of patients with atrial fibrillation (a chronic heart disease that
manifests as irregular heartbeat), was around 70% [5]. While it
is still better than what was reported in [2], we feel that it could
be further improved if barriers to compliance are identified
and addressed.
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Our multidisciplinary team designed a new component that
can be integrated within the MobiGuide architecture:
Motivational Patient Assistant (MPA). This component provides behavioral support delivered via interventions firmly
based in health behavior theories. These interventions are delivered via mobile technology in a patient’s home environment. Using a data mining technique called dominancebased rough set approach (DRSA) [6] applied to the historical
patient data, we are able to identify those behaviors and psychological characteristics (psychobehavioral targets) that have
the greatest impact on patients’ compliance [7]. Taking an
individualized approach based on each patient’s characteristics, the MPA generates personalized interventions using identified psychobehavioral targets by (a) determining the patient’s readiness to make a behavior modification and (b) delivering behavior modification interventions that help motivate the patients and move them to more advanced readiness
states. Furthermore, MPA provides educational and reporting
interventions that are sensitive to the patient’s readiness for
change.
Our research provides new insights into the design of mobile health (mHealth) applications. Building on the IDEAS
framework (described later in the text) we show how conceptual phases (especially Bideating^) are translated into an architectural framework and how such a framework is evaluated
with potential end-users (patients and physicians). Our research contributes to the ongoing discussion on the design
principles for mHealth applications.
In this paper we describe the generic architecture of the
MPA and report results of a preliminary assessment of the
proof-of-concept prototype. This assessment engages a hematologist and two patient advocates who were presented with a
hypothetical scenarios describing an atrial fibrillation (AF)
patient on the anticoagulation therapy.

Related work
Information-system development process
for theory-based mHealth systems
There is an ongoing discussion regarding systematic approaches that should guide development of mHealth applications for behavioral interventions. Schnall et al. [8] advocates
following an Information Science Research (ISR) framework
that allows for the incorporation of end-user feedback and
expert opinion in the development process. Collins et al. [9]
propose that mHealth applications should be developed using
a Multiphase Optimization Strategy (MOST) framework that
according to the authors helps identify interventions that do
not bring sufficiently effective results. Mummah et al. [10]
modified the classic information system development lifecycle to include concrete steps from behavioral theory, design

J Med Syst (2018) 42: 234

thinking, and user-centered design. Their framework, includes
four main phases: Integrate, Design, Assess, and Share
(IDEAS), comprising ten specific phases (I: empathize, specify, ground; DE: ideate, prototype, gather, build; A: pilot,
evaluate; and S: share interventions and findings). While all
three design frameworks share commonalities in terms of
problem identification and translation of key behavioral modalities into targeted interventions and subsequently mHealth
application functionality, we decided to follow and extend the
IDEAS framework given its focus on translating behavioral
theories into conceptual mHealth modalities [11, 12]. We follow this framework with a detailed method for ideating a
backend architecture as well as interactive graphical userinterface designs.

Factors affecting compliance: A focus on patient
engagement
We start by reviewing the factors that impact compliance to
treatment recommendations, focusing on patient engagement,
which we have determined in prior work [7] to be a predictor
of good compliance. A systematic review of factors affecting
patients’ compliance [13] identified patient-related factors as
demographics, smoking or alcohol intake, cognitive function,
and history of compliance; and therapy-related factors such as
route of administration of medications, treatment complexity,
duration of therapy, medication side effects, and the degree of
behavior modification required.
In general, patient engagement is a predictor of compliance
to therapy recommendations [14–16] and was found to be a
predictor for compliance to anticoagulants for AF patients [6].
Patient engagement in therapy is particularly pertinent for
chronic diseases and symptomless conditions where high
levels of self-motivation are required from patients to selfmanage their disease over a long time-period.
Patient engagement is defined by four interrelated dimensions [17]. These include ownership, informed choice, navigation, and commitment. Ownership denotes a situation when
patients perceive having the lead role in their health and
healthcare decisions. Informed choice describes a situation
where patients educate themselves about their condition (such
as the symptoms and treatment options) and are capable to
make knowledgeable choices. Navigation concerns a person’s
ongoing management of their condition, in particular their
confidence in their ability to ask questions and find answers,
which subsequently leads to the ability to make informed
choices and possibly adjustments of therapy (preferably according to adjustment protocols previously agreed with doctors). The ability to make choices and adjustments to therapy
depends on both informed choice and navigation. Therefore,
in our study and in the rest of this paper, we refer to both as
Binformed decision making^. The final measure of patient
engagement, commitment, refers to a patient that is
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Table 1

Application of the IDEAS framework for developing the MPA for AF

IDEAS
phase

Application to the MPA for the AF domain

Empathize

Research question: how can we increase patients’ compliance to health recommendations using an mHealth app?
Focused the inquiry by drawing insights from the MobiGuide project (see Introduction) and from hematologists,
who provided features that could potentially predict compliance to anticoagulation.
Reviewed published literature from different fields (e.g., health psychology, mHealth,
pervasive health^ for definitions of those feature (e.g., patient engagement—see Related work section).
Translated the broad goal of compliance into a specific target behavior—increasing patient engagement—by mining patients’ data to
predict influential target behavior that affects compliance [7] (see Introduction).

Specify
Ground
Ideate

Identified behavioral theories, as reviewed in BBehavior modification theories that guide MPA development^ section.
Developed strategies for translating behavioral theories and user and expert insights into conceptual features of MPA;
Novelty: developed strategies for supporting these conceptual mHealth app features as a concrete backend architecture
(MPA architecture section) and graphical user interface features (Proof of concept implementation of MPA in the AF domain: the
extended ideation phase section)

Prototype

Developed the architectural framework and associated proof of concept prototype for the AF domain
(Proof of concept implementation of MPA in the AF domain: the extended ideation phase section)
Gathered user feedback via an evaluation study (Preliminary assessment section)

Gather

continuously involved and consistently taking steps to manage their health condition.

Interventions for increasing compliance
Specifically for chronic diseases, interventions that have improved compliance include case management (patient assistance in developing, implementing and coordinating medical
care plans with health care providers), and patient education
with behavioral support [18].
Increasingly, interventions for achieving compliance are
implemented as mHealth interventions and have been used
to support behaviors such as weight control [19, 20], physical
activity and fruit/vegetable consumption [21].
Riley et al. [22] note the paucity in 50 reviewed studies of
discussion regarding health behavior theories (such as SelfFig. 1 Architecture combining
MobiGuide and MPA (DSS =
decision support system)

Determination Theory and the Trans-Theoretical Model
reviewed below) that underpin health behavior interventions
delivered via mobile technologies. A good example of a study
that discusses underlying theory is [12], which relied on
Fogg’s Behavioral Model (FBM) for providing mHealth interventions for weight loss. This same study highlighted a
well-documented feature of mHealth interventions, namely
decline in engagement over time, as weight loss was not
sustained in the long-term. In a systematic review on compliance to medications, Costa et al. [23] posit that one of the
reasons for poor long-term compliance with mHealth interventions is the lack of comprehensive theoretical models to
explain non-compliance and that interventions that are supported by behavior models and theories are more successful
than those based on intuition. Building on these conclusions,
MPA’s mHealth interventions are guided by the behavior
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Components of the MPA

Component name

Description

MPA Intervention Base

Stores Abraham and Michie’s [27] behavior change techniques (adapted into interventions focused on a specific health
condition, AF for our proof of concept implementation) in a structured format. Each intervention is characterized with 3
elements: (a) applicability conditions based on patient data (e.g., TTM stage, diagnosed comorbidities, prescribed
treatment) that specify when the intervention should be selected and used; (b) a sequence of activities that define the
intervention (e.g., presenting specific educational materials or running an interactive reporting tool); and (c) success
conditions that specify when the intervention is successful and refer to patient data collected via monitoring
(e.g., portion of educational materials read by patient) and to duration of intervention (e.g., using a reporting tool).

MPA Controller

Controls the MPA by actively monitoring the patient record for changes and invoking corresponding components as
needed (e.g., when anticoagulation therapy of a new patient starts).
Infers the patient’s baseline TTM stage from data capturing his/her characteristics available when the management starts
(e.g., demographics and history of disease) and responses to questionnaires suggested within the TTM framework.
Applied questionnaires and inference rules are based on expert knowledge and need to be customized to a specific
clinical problem.

TTM Stage Assessor

TTM Progress Assessor

Intervention Selector
Intervention Executor and
Monitor

Verifies whether the patient is ready to move from the current TTM stage to the next one. Specifically, it checks if success
conditions of applied interventions have been satisfied given the data collected via monitoring. If yes, then the patient is
moved to the next phase, otherwise the patient stays in the current one. Moreover, if the patient stays in the same TTM
stage for a prolonged period of time that exceeds a defined threshold, then he/she is demoted to the previous stage.
Selects appropriate interventions from the intervention base by matching their applicability conditions with the current
patient data.
Delivers selected interventions to the patient—it iterates over the sequence of activities defined for a given intervention and
executes them. It also monitors how the patient interacts with these interventions (e.g., what educational materials the
patient has marked as read). Results of monitoring are stored in the patient record.

modification theories introduced in BBehavior modification
theories that guide MPA development^ section.

Methods
Application of the IDEAS framework

Behavior modification theories that guide MPA
development
The Transtheoretical Model (TTM) [24] provides a comprehensive understanding of behavior modification. It allows
classifying patients according to which stage they are in their
readiness to change: pre-contemplation (the patient has yet to
recognize the need to change); contemplation (the patient considers change); preparation (the patient plans to take action);
action (the patient begins to change); and maintenance (the
patient has succeeded in changing and focuses on the incorporation of the new behaviors in his/her lifestyle). TTM acknowledges that some patients relapse to earlier stages.
Self-Determination Theory (SDT) [25] maintains that positive health outcomes are fostered when patients experience
autonomous (rather than controlled) motivation and greater
feelings of competence. In addition to ensuring that patients
are motivated and feel capable of engagement, FBM [26]
contends that behavior modification must be triggered by
tying the new behavior to a cue or to some cyclical event
(e.g., before bedtime). Interventions for behavioral support
include self-regulation via self-monitoring [19], action planning [21], and goal-setting [20]. A comprehensive taxonomy
of behavior modification techniques used in interventions was
developed by Abraham and Michie [27].

Table 1 details our application of the first six phases of the
IDEAS framework for developing the MPA for AF. The novelty of our work is that we have moved beyond ideation phase
and show how conceptual behavioral interventions can be
translated into an architectural framework and associated
graphical user interface (GUI) of a prototype mHealth app.
These specific translations are explained in BMPA architec
ture^ section, which focuses on the architecture and BProof
of concept implementation of MPA in the AF domain: the
extended ideation phase^ section, which focuses on GUI
design.

MPA architecture
In Fig. 1 and Table 2, we present the MobiGuide [4] architecture integrating the MPA. MPA and MobiGuide share common architectural components with a mobile client interacting
with the patient, a backend decision support system (DSS) and
a knowledge base. In MobiGuide, the knowledge base stores
encoded clinical practice guidelines; while the MPA’s knowledge base store all interventions (see Table 2 for a definition of
Intervention). MobiGuide and MPA use the patient record to
store and exchange data related to the patient, his/her therapies, and the support being provided.
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Fig. 2 Architecture for the MPA
(DSS = decision support system)

Expanding MobiGuide with the MPA allows for a comprehensive approach to improving patient compliance by:
–

–
–

Providing a set of interventions to support patient engagement. These interventions include education about the
disease and its management, activities for supporting behavior modification, means for reporting compliance
(medications taken, diet, and exercise), symptoms, and
risky events (for example, dental surgeries, which carry
a bleeding risk), and summaries of the patient’s progression along the compliance continuum and their perception of well-being.
Tailoring these interventions to the specific patient, according to TTM [24], SDT [25], and FBM [26],
supporting patient’s autonomy and competence.
Supporting the re-evaluation of engagement, allowing patients to assess their competence and autonomous
(volitional) motivation for engagement.

Typically, these activities only happen at the follow-up
appointment with a physician while the patient remains
unsupported in between visits. The MPA provides continued monitoring and engagement with the patient in between visits to support compliance with anticoagulation
therapy.

The architecture for the MPA is shown in Fig. 2 and its
individual components are described in Table 2. MPA acts
according to the process that is controlled and enforced by
the MPA Controller. When a new patient starts to interact with
the MPA, the TTM Stage Assessor establishes the patient’s
baseline TTM stage. Then the Intervention Selector chooses
applicable interventions from the MPA Intervention Base.
These interventions are passed to the Intervention Executor
and Monitor that delivers them to the patient and monitors
the patient’s interactions. After the interventions have been
applied, the TTM Progress Assessor evaluates the patient’s
progress in using the interventions. Based on the TTM
Progress Assessor’s determination, if the patient should be
promoted to the next TTM stage or because of a relapse,
demoted to the previous one, he/she is presented with explanation on the TTM stage change and asked for confirmation,
new interventions are selected, and the cycle repeats.
Otherwise, if the patient’s stage does not change, MPA keeps
executing the currently selected interventions.

Proof of concept implementation of MPA in the AF
domain: The extended ideation phase
AF treatment may include medications for controlling heart
rate and rhythm, which aim to relieve patient’s symptoms, and

Patient has explored the barriers and has been reporting
Daily reporting of:
regularly and achieving compliance >80% for all the
-symptoms
reporting interventions in 1 month
-compliance to
anticoagulation medication
-risky events
-wellbeing
-engagement summaries
(daily, weekly)

Engagement (e.g., benefits,
Exploration of pros of
risks—communicated in text and as a video
engagement
interview with an AF patient)
AF facts (e.g., etiology, therapies, management)
Risk of stroke and its treatment by anticoagulants
Barriers and ways to
Preparation/Action As above plus:
remove/mitigate them
Lifestyle (e.g., diet, exercise);
Self re-evaluation questionnaire
Self-care (e.g., risky events)
Action planning and goal setting

None

Patient has explored 80% of educational materials and has
indicated at least 3 pros of engagement

J Med Syst (2018) 42: 234

Contemplation

Behavior modification interventions Reporting interventions
Educational interventions
TTM Stage

Table 3

Education, behavior modification and reporting interventions: ideated concepts featured in the MPA prototype

Combined success conditions
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those to thin the blood (anticoagulants), which aim to prevent
embolization and reduce the risk of stroke. While there is no
definite scientific evidence about the efficacy of the former,
there is strong evidence on the stroke prevention effect of
anticoagulants, and consequently on their effect on improving
survival and quality of life [28]. As well, there is evidence that
patients’ compliance to anticoagulation, which sometimes requires attention also to drug-food interaction, is often low
[29]. For this reason, for the MPA proof of concept prototype,
we decided to focus on behavioral modification that targets
increasing patients’ engagement in their health and to increase
compliance to anticoagulation therapy.
MPA targets the TTM stages that lend themselves to a
mHealth coaching tool: contemplation, preparation, and action. Hence, we assume that patient is at least in the contemplation stage and we have combined the preparation and action stage, because the interventions for these two stages overlap. We assume that MPA’s usage is discontinued once the
patient reaches the maintenance stage and from that point,
the patient uses MobiGuide’s reporting and planning functions. In our setting, we automatically infer when the patient
is ready to transition to the next TTM stage (see last column of
Table 3 for a combination of success conditions of applicable
interventions), which allows us to give the patient control
about moving to the next stage. This improves on the simple
approach of the original TTM model which asked the patient
if she/he is ready to make a change within 6 months, a month,
or has already made the change during the past 6 months [30].
To evaluate the potential usefulness of the MPA to patients
before a final system is developed, we developed a prototype
and prepared a survey instrument that covers two patient scenarios—one for the contemplation and the other for the
preparation/action TTM stages. The survey instrument includes a questionnaire and a prototype of the MPA mobile
client (see relevant screen shots in Figs. 3 and 4).
The GUI design used lessons learned from the MobiGuide
project, followed Nielsen’s ten usability heuristics for user
interface design [31], and incorporated well-established conventions such as ones used by Facebook and LinkedIn. Before
presenting the prototype for evaluation by the patients and
physician, we iteratively revised the GUI design following
feedback from a founder of a company developing mHealth
applications, by a human-computer interaction expert from
academia, and by our group members and our graduate students. Table 3 presents the ideation concepts that we conceived for the TTM stages, which focus around education,
behavioral modification, and reporting interventions. Table 4
details how concepts by Abraham and Michie were translated
into specific GUI designs supporting the three categories of
interventions. Figures 3 and 4 present selected screen shots of
the MPA mHealth application for the AF domain.
For each TTM stage, interventions are focused on educating patients about AF and on motivating behavior

J Med Syst (2018) 42: 234
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Fig. 3

Behavior modification interventions for the contemplation stage:
exploration of the pros of engagement. The pros address different
categories including body—which refers to physical (e.g., maintaining
good health by decreasing the risk of stroke) and behavioral (e.g.,
feeling comfortable talking about your health condition with family and
support team); mind (e.g., feeling optimistic about the future, engaging in
meaningful activities); and relationships (e.g., having long-term plans
with family, living life fully). Each quadrant represents a different screen

modification (Table 3). Indeed, increasing compliance
through education (know what) is necessary to affect behavior
modifications, and motivation for behavior modification is
sustained when patients know how and why a new way of
anticoagulation is necessary. This facilitates patients’ informed decision-making regarding the anticoagulation therapy for AF. Specifically, as per [27], the focus of educational
materials is on providing information on behavior-health links
(e.g., behaviors that increase bleeding risk for the AF patients). In addition to the links, we provide a short interview
(see Appendix Table 7) with an AF patient from Italy who
explains his view of how an engaged patient is managing his
AF condition; this follows Abraham and Michie’s [27] intervention of modeling or demonstrating the [engagement]
behavior.
To learn about the patient’s interests in educational material, we observe the clicks and time spent on different educational materials, such as those related to complications of AF
(e.g., stroke, intracranial bleeding, depression). This information could be used to update the patient record so that these
changes could be propagated to the MobiGuide system.
The behavior modification intervention of the contemplation stage adapts the smoking cessation benefits suggested by
Prochaska [30] to the AF domain. To acquire the AF management benefits most appealing to a patient (Fig. 3), we drew
inspiration from the Photographic Affect Meter [33]—a tool
for measuring affect, in which users select from a wide variety
of photos the one which best suits their current mood. In our
adaptation, revised following comments from prospective
users, we show photos corresponding to different categories
of benefits of managing AF so that patients understand the
pros of being engaged in their anticoagulation therapy. A short
textual title is associated with each photo, otherwise the photo
is too abstract in meaning. Clicking on one of the photos
shown on the screen uncovers a textual description of a benefit
of engagement for the well-being of an AF patient. The patient
can then check whether she/he identifies with this pro.
Figure 3 shows examples of pros belonging to several categories of well-being.
One of Abraham and Michie’s interventions is to provide
encouragement to the person undergoing behavior modification. This is especially important for patients who are in the
contemplation stage. Therefore, on the first click on a link to a
behavioral intervention, patients will receive an encouraging
message congratulating them and noting that by expressing
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interest they have already demonstrated that they are
progressing. This is illustrated in Fig. 3.
For patients in the preparation/action stage, we designed
behavior modification interventions, some of which are
shown in Fig. 4. Figure 4a shows interventions for identifying
and mitigating barriers for being engaged. Interventions for
planning engagement actions are shown in Fig. 4b; they include setting goals with deadlines in their calendar, an idea
adapted from [34]. This allows patients to take ownership of
the management of AF and become committed. The patients
also receive medication reminders at times they set in the
calendar.
The behavior modification interventions for the
preparation/action stage include daily reporting of symptoms,
medication compliance, risky events (i.e. bleeding), and the
patient’s overall well-being (Fig. 4c). Daily and weekly reports are shown to the patients at their leisure or at predefined times (Fig. 4d). The report presents the patients’ compliance to anticoagulation therapy, self-reporting of AF symptoms and risky events, and their feeling of well-being. These
reports allow a patient to perform self-monitoring—by comparing his/her report to the goals they set. The report also
encourages the patient to complete incomplete reports by inviting them to Bincrease your score^; these interventions,
marked in italics above, are three of the Abraham and
Michie techniques. Further techniques are discussed in
Table 4.

Preliminary assessment
We conducted an exploratory study of the main ideas behind
the MPA to learn whether the general types of proposed interventions to promote patient engagement are appropriate, and
if the process that drives these interventions is appropriate.
Questionnaires were prepared to assess perceived usefulness
and perceived ease of use of the MPA proof of concept prototype and whether patients were likely to use the fullyfunctioning MPA in the future. These two dimensions of the
assessment were inspired by the Technology Acceptance
Model questionnaire [35]. The questions were tested with a
sample of student users. The questions did not concern
MobiGuide, as its assessment is reported in [4, 5].
One hematologist from the Ottawa Hospital and two patient advocates associated with the Hematology and
Thrombosis Clinic of the hospital were recruited via a purposeful sampling approach. None of them were involved with
the development of the architectural framework or MPA prototype. Ethics approval was obtained from the ethics review
board of the hospital. The participants accessed the prototype
and the survey instrument via a web-browser. They were given a brief explanation about the purpose of the MPA and were
informed that they were expected to answer questions and
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(a) Barriers to engagement

(c) Reporting

(b) Action planning and goal setting

(d) Daily and weekly summaries

Fig. 4 Behavior modification interventions for the preparation/action
stage: a barriers to engagement; b action planning; c separate reporting
screens for medication compliance, additional reporting (diet &

symptoms), and risky events; d daily and weekly summary screens.
Each quadrant represents a different screen
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Translation of behavioral techniques into conceptual features of MPA and their concrete GUI design

Behavioral techniques [27]

Conceptual features of MPA

Concrete GUI design

1. Provide information about the links between
behaviors and health
2. Provide information on consequences

Patient education screen

4. Prompt intention formation

Goal setting screen

5. Prompt barrier identification.

Barriers screen, as part of behavior modification Figure 4a: a list of barriers is displayed, framed in
interventions. It addresses barriers following
a non-judgmental way. For example, instead of
the categories suggested in [32].
saying Black of routine^ the phrase used is
BI fail to take my medications every day
automatically at a fixed time or on fixed
occasions^. Clicking on a barrier label displays
an explanation of an action that can help
overcome the barrier and a hint explaining how
a feature in the app can support such action

6. Provide general encouragement.

For the TTM contemplation stage: feedback
messages related to system usage

On the first click, either on a link to a behavioral
intervention or on educational material,
patients receive an encouraging message
congratulating them and noting that by
expressing interest they have already
demonstrated that they are progressing (Fig. 3)

For the Action stage: The Daily Report screen
encourages completion of self- reporting
actions

BIncrease your score^ button (Fig. 4d) provides
access to self-reporting actions that the patient
has not used that day yet and could increase
his/her daily compliance score

7. Set graded tasks.

Different context of health modification
interventions for each TTM stage; tasks
increase in difficulty as TTM stages progress

8. Provide instruction.
9. Model or demonstrate the behavior.

Education screen
Interview with a patient exhibiting the targeted
health behavior

10. Prompt specific goal setting.

Goal setting feature

For the Contemplation stage: learning about pros
of the behavior
For the Action stage: goal setting, addressing
barriers, action planning, reporting,
self-re-evaluation
See Items 1 and 2 above
Video of a patient explaining how he is practicing
good health behavior—what good
engagement entails
Setting deadlines for goals in the Calendar
intervention (Fig. 4b)
Observing clicks and the time spent on particular
education links and behavior-change
modalities in order to update MobiGuide’s

The screen includes a detailed menu:
-Lifestyle (should I watch my diet and
consequences of not adhering to dietary
recommendations?)
-Self-care (behaviors that increase risk and their
consequences, events that increase the risk of
bleeding, stress, sports, travel)
-Engagement (what does it mean to be engaged?
Interview with a patient explaining how he
practices good health behavior, barriers to
engagement
-Facts on the targeted health condition
Daily and weekly summary screens that contain See Fig. 4d for daily and weekly reports
3. Provide motivation by visibility of positive
numerical scores of a scale of 0–100: people -provides a number between 0 and 100 that
examples of others’ behavior and approval of
like to be evaluated using a single clear
summarizes the overall score for the targeted
others for these behaviors (e.g. conveying that
indicator and are used to seeing scores on a
behavior (engagement). Shows it also in green
others take their medications)
scale of 0–100.
vs. white stars that add to a total of 10 possible
stars. This number is calculated based on
reported health behavior components
including prescriptions followed (medications,
diet, measuring health outcomes), reporting of
symptoms and risk events, reading educational
material, reporting, using health modification
interventions
Supported via a Calendar feature for setting goals
with deadlines (Fig. 4b)
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Table 4 (continued)
Behavioral techniques [27]

Conceptual features of MPA

Concrete GUI design

11. Prompt review of behavioral goals.

Daily report screen

user model and thereby personalize goals and
suggested actions
Medication goals are shown as photos of the pills
to be taken daily. Reporting goals are shown as
well (Fig. 4c).

12. Prompt self-monitoring of behavior.

Reminders for completing the Daily Report +
motivating the patient to report his/her
progress, which awards points

Reminders are delivered once a day, at a time
predefined by the user
Also see Item 18 below

13. Provide feedback on performance.

Daily and Weekly summary screens

As shown in Fig. 4d, the Weekly Summary
shows the mutual progression over time of the
patient’s score and his/her overall feeling so
that the patient could potentially observe a
connection between the two.
To report the patient’s own feeling that day
(Fig. 4d), the patient drags to position a cursor
on a line scaling from bad (cloud) to good
(sunshine).
A bar graph shows the score according to more
specific components.

14. Provide contingent rewards.

Virtual rewards in the form of points

Figure 4d shows the points and stars awarded to a
patient for his daily behavior. See Item 3 above

15. Teach to use prompts or cues.

Reminders

16. Agree on behavioral contract.

Patient journey from stage to stage of the TTM

17. Prompt practice.

Daily report screen

18. Use follow-up prompts.

Motivate the patient to report his/her progress,
which awards points

Reminders for reporting and for taking
medications and measurements at times
personalized to the patient
The GUI guides patients through these
milestones, informing and
congratulating/encouraging them as they pass
each stage
The reporting daily summary provides this as it
encourages the patients to repeat actions daily
The Reporting and the Daily summary screens
(Fig. 4c,d) include a button for Bincreasing
your score^. The total number of pending tasks
(for increasing the score, similarly to Facebook
or LinkedIn that indicate what percentage of
the user profile is still incomplete and provide
links for completing it) are shown and can be
clicked to enter one task at a time. The types of
tasks are described in Item 3 above for
explanation on how the score is calculated.
Color conventions used in many other successful
mHealth apps promote normative behavior by
using green as desired behavior and red as
undesired behavior. Too much or too little
consumption is marked in red (discouraged)
with arrows marking the trend
In the Reporting screens (Fig. 4c), completed
reporting items are shown in full color whereas
those waiting to be completed are shown with
no fill. In the Daily Summary screen (Fig. 4f),
reported items are shown as green check marks
or red Xs, and those waiting to be reported are
shown as grey question marks.
As in [11], a bar graph shows the patient’s own
average score and the score of the peers
The barriers screen includes an item addressing
lack of social support (BI really would need
help on an everyday basis (and particularly
related to my treatment with medicines).

19. Provide opportunities for social comparison. Weekly summary screen
20. Plan social support or social change.

Barriers screen
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Table 4 (continued)
Behavioral techniques [27]

Conceptual features of MPA

21. Prompt identification as a role model.

Pros of engagement screen.

22. Prompt self-talk. Encourage use of
self-instruction and self-encouragement
(aloud or silently) to support action

Mapping instructions to specific photographs
visualizing therapies

23. Relapse prevention

Concrete GUI design
But I do not get any help^). For this barrier, it
encourages the patient to ask their provider
about a social support group or a Bbuddy^ who
could provide tips (Fig. 4a).
Addressed under the BMind^ menu of the Pros of
Engagement behavioral intervention—setting
a good example to others. See Fig. 3 for
additional examples.
Show photos of medications and monitoring
equipment specific to the patient. See example
in the Daily Summary screen (Fig. 4b)

24. Stress management

Not addressed in the current prototype.
The architecture includes a component that
checks for reporting of a relapse to move the
patient to a previous TTM stage
Part of the Education screen

25. Motivational interviewing

List of pros of the targeted health behavior

The pros are delivered as a Photographic Affect
Meter of photos and test for each pro (Fig. 3).
The patient clicks the pros with which they
identify.

26. Time management

Barriers, Goal Setting, and Action planning
screens

Addressed with a calendar feature (Fig. 4b)

make comments about the perceived usefulness and usability
of the prototype system for the two patient scenarios. The
hematologist also assessed whether the MPA would help his
patients with compliance to anticoagulation therapy (perceived usefulness). The rationale behind this our purposeful
sampling approach is that if physicians and motivated patients
will not find MPA useful, then it is unlikely that different
conclusions would be drawn from a larger sampling frame
and associated study design.
The results of the assessment are provided in Tables 5 and 6
(the first column includes the questions from the questionnaire). Table 6 includes questions that only the physician
was asked to answer. One of the patients provided their own
definitions of engagement; it corresponded well to the one we
have been using (rows 1 and 2). In general, both patients were
highly positive about the usefulness of the MPA for increasing
engagement.

Discussion
Using the MPA proof of concept prototype developed for the
AF domain, we explained our extension of the Ideation phase
(of the framework for developing effective mHealth interventions to influence health behavior). This extension supports
the translation the ideation concepts into concrete backend
architectural components and GUI designs that implement
behavioral interventions. The MPA architecture allowed extending MobiGuide’s functionality with support for patients

See item Items 1 and 2 above

who need to be more engaged in their health to improve their
compliance to therapy. We evaluated the proof of concept
MPA prototype in the AF domain, yet the proposed design
is generic enough to be applied to different chronic diseases.
The MPA architecture draws on theoretical foundations
from behavioral theories. The MPA educates patients about
their disease, its risks and management options, such that patients become competent to effectively manage their disease at
home. The behavioral modification interventions were designed to help patients become motivated (pros of engagement), take ownership of disease management (action planning), commit to this management (goal setting), and practice
informed choice of interventions and diet to manage their
disease (educational materials). We customized the educational material and behavioral modification interventions to the
patient’s TTM stage.
In this paper, we presented the architecture of the MPA,
describing its conceptual and GUI features and how they draw
on theoretical foundations of behavioral theories. Our preliminary assessment of the main concepts behind MPA prototype
developed for the AF condition and patients’ compliance to
anticoagulation therapy has shown that the patients and physician see the potential benefit of the MPA for increasing patients’ engagement and compliance. The hematologist was
confident about recommending mHealth app like MPA to
the patients and believes that patients would be more engaged
when they plan actions/set goals using the MPA. All evaluators stressed the importance of providing simple and easy to
understand interventions.
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Table 5

Results of the preliminary assessment by patients and physician

Question

Patient 1

Seeking participants’ perceptions about what engagement means for them
1. Being engaged means…
Seeking further comprehension through
education and exposure. Volunteer
participation in advanced research to
receive further insights.
2. Engagement activities that I do and their Produce a shift in my health beyond what
benefits (pros)
medical professionals alone can produce
through lifestyle advice, comply to diet
recommendations and perform advanced
physical exercise.
Perceived usefulness
3. Patient education materials provides
Strongly agree
clear information about the disease and
its symptoms

Hematologist

–

NA

–

NA

Strongly agree
Provide educational
material only for the
type of medications
that the patient is
prescribed

Strongly agree

Strongly agree

Strongly agree
Initial educational materials should be
basic and their sophistication
should increase as the patient
becomes more engaged.
Provide educational material only for
the type of medications that the
patient is prescribed
Strongly agree
Play up risk of stroke in order for a
patient to better understand
trade-offs between risk of stroke
and possible side effect of bleeding.
Strongly agree

Strongly agree

Strongly agree

Strongly agree

Strongly agree

Strongly agree

Strongly agree

Strongly agree

Strongly agree

Strongly agree

Strongly agree

Strongly agree

Strongly agree

Agree

Strongly agree

Strongly agree

Strongly agree

Strongly agree

Strongly agree

Strongly agree

Strongly agree

Strongly agree

Agree

Strongly agree

Strongly agree

Agree

Strongly agree

Strongly agree

Strongly agree

Strongly agree

Strongly agree

Strongly agree

Strongly agree

Strongly agree

4. Patient education materials provides
Strongly agree
clear information about the disease risks,
treatment options and impacts on lifestyle

5. The Pros of Engagement behavioral
modification intervention makes it clear
how to internalize reasons for change
6. The Barriers to Engagement behavioral
modification intervention clearly
identifies possible barriers to engagement
7. The Action Plan behavioral modification
intervention helps to establish a routine
thanks to the action plan
8. The Action Reminders behavioral
modification intervention helps with
promoting positive behavior
9. Patients with AF will find the MPA app
educational
10. Patients with AF will be better
motivated when using the MPA app
11. Patients with AF will be encouraged to
focus on their AF in a positive manner,
e.g., take control over the management of
their condition
12. If the full MPA app was developed,
I would recommend the MPA app to a
friend or family member
13. If the full MPA app was developed,
I would buy the MPA app for myself
14. MPA app should be Bprescribed^ by
physicians to their AF patients
Perceived ease of use
15. The daily/weekly summary is helpful,
presents information that is easy to understand and allows a reflection about
how the disease is managed disease is
managed
16. Patients with AF will find the purpose
of the MPA app clear

Patient 2

Future work will target the limitations of this study, which
include: (1) evaluation with a large group of patients, and (2)

Agree.
The language should be
simplified.

implementing the MPA architecture as part of an expanded
MobiGuide decision support system.
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Table 6

Answers of questions that only the physician was asked

Question

Answer

Perceived usefulness
17. Clinical expert’s opinion regarding the application of TTM stages
18. Clinical expert’s opinion regarding the thresholds for automatic advance
between TTM stages
19. Clinical expert’s opinion regarding the appropriateness of the pictograms
of the pros of being engaged as a means for increasing intrinsic motivation
20. Clinical expert’s opinion regarding the appropriateness of the educational
material for increasing competence and intrinsic motivation
21. Clinical expert’s opinion regarding the appropriateness of triggers
(reminders at specific times in the day for medications and for the
daily/weekly summary)
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thank the students in our research groups for providing comments on the
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Having stages and customized interventions is a good idea
While I do not know about this model, this seems to be good idea
Strongly agree that the pictograms are useful
Liked the interview with the engaged patient.
Had specific comments about how to improve the presentation of the
educational materials (see Table 5, Row 3)
Liked the idea of a centralized system that would integrate all communication
sent to patients along with support structure patients need. Would be good if
system integrates with the email reminders with the dosages that are sent to
patients on one of the anticoagulants every week.

clarity of the earlier versions of the prototype and on the patient scenario
questionnaire.

Appendix 1

A short interview with an AF patient from Italy who explains his view of how an engaged patient is managing AF condition

Q Do you have any obstacles from adherence?
A Adherence has never been an issue for me, I take regularly my pills. I know that during a chronic treatment it is important to avoid big changes in drug
concentration in our body, and this is just what happens when you skip doses. For my comfort I want to be protected by the drug during the whole day.
Q Did you get your knowledge from physicians?
A Nobody gave me explanations about drugs and about the importance of adherence. I recognize that this is an issue for many patients, and I would
have appreciated more explanations from my doctors. On the other hand, whenever I asked doctors, they provided satisfactory answers (this is to
say that doctors are not proactive in giving spontaneous explanations).
Q Why did you have the ablation procedure?
A Amiodarone shows a long-term toxicity (this is information that the interviewed patient knows, but most patients do not). I am getting old,
and I would like to avoid damaging my liver or my kidneys, that would be a big problem in some years. AF symptoms were worsening.
I had a couple of episodes with associated severe dizziness that also led to hospital admission. Also my wife was becoming stressed by those
episodes. Multiple drug regimen in the long term caused a continuous sense of fatigue. Ablation is a surgical intervention, and if it is my last chance
to recover from AF symptoms, it’s better to do it now (the patient is 78 years old).
Q Does dietary care bother you?
A I have been abundantly and very carefully informed by doctors and nurses (specialized about OACs - oral anticoagulants) on green leaf foods, lentils,
cauliflower, broccoli, asparagus, etc. Consequently, except for lettuce, broccoli and asparagus, which I banished from the table, I eat habitually
other vegetables including beans, taking care to vary the type but not the quantity, to keep the vitamin K intake range quite uniform. It goes without
saying that the diet does not bother me.
Q Do you fear AF episodes?
A More than fear is the hassle of having to endure fibrillation, while fear is linked to a possible episode of TIA (transient ischemic attack) and hence the
thought goes to the effective pharmacological coverage. Unfortunately, the onset of AF symptoms is unpredictable, it may happen during day or
night, I daily use the blood pressure device to check not only the pressure but also the heartbeats (sometime episodes are asymptomatic).
When a symptomatic episode ends, I only think about recovering to a normal and happy life!
Q Did your symptoms improve after the ablation?
A This aspect improved a lot. I do not think so much about AF because the symptoms after ablation do not appear (at least until now), so the daily life is
no more compromised.
Q What does it mean to you to be engaged in your treatment?
A It means to have counseling and explanations by my caregivers and understand the mechanisms of the disease and of the treatment, in such a way that
I may face the problems more efficiently, and solve the minor problems by myself. I also like very much to be involved in research projects and to
experiment new devices. Now that I am retired, this reminds me of the time I worked (the patient was a technician in an otolaryngology ward).
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